Author:
Testa U.,Care A.,Montesoro E.,Fossati C.,Giannella G.,Masciulli R.,Fagioli M.,Bulgarini D.,Habetswallner D.,Isacchi G.,Pelicci P. G.,Peschle C.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Immunology,Immunology and Allergy
Reference49 articles.
1. Anderson PM, Bach FH, Ochoa AC (1988) Augmentation of cell number and LAK activity in peripheral blood mononuclear cells activated with anti-CD3 and interleukin-2. Cancer Immunol Immunother 27: 82
2. Aribia MHB, Leroy E, Lantz O, Metivier D, Autran B, Charpentier B, Hercend T, Senik A (1987) rIL-2 induced proliferation of human circulating NK cells and T lymphocytes: synergistic effects of IL-1 and IL-2. J Immunol 139: 443
3. Atkins MB, Gould JA, Allegretta M et al. (1986) Phase I evaluation of recombinant interleukin-2 in patients with advanced malignant disease. J Clin Oncol 4: 1380
4. Beckner SK, Maluish AE, Longo DL (1987) Lymphokine-activated killer cells: culture conditions for the generation of maximal in vitro cytotoxicity in cells from normal donors. Cancer Res 47: 5504
5. Bich-Thuy LT, Lane HC, Fauci AS (1986) Recombinant interleukin-2 polyclonal proliferation of in vitro unstimulated human peripheral blood lymphocytes. Cell Immunol 98: 396
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献